ResMed的总法律顾问出售股票,而公司却打破了收入估计,看到机构收购。 ResMed's General Counsel sold shares, while the company beat earnings estimates and saw an institutional buy.

医疗器械供应商ResMed Inc.的市值为300.07亿美元, 总法律顾问迈克尔·J·莱德于4月1日出售64股股票, ResMed Inc., a medical device provider with a market cap of $30.07 billion, saw its General Counsel, Michael J. Rider, sell 64 shares on April 1st, reducing his ownership by 0.72%. ResMed 最近报告称，每股收益为 2.43 美元，超出预期 0.14 美元。 ResMed recently reported earnings per share of $2.43, beating estimates by $0.14. 机构投资者Franklin Resources Inc.的股份增加了4 537万美元。 Institutional investor Franklin Resources Inc. increased its stake by $45.37 million. 分析员预测ResMed将在本年度发布9.47 EPS。 Analysts forecast ResMed will post 9.47 EPS for the year.